Cargando…

From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation

The central nervous system and gastrointestinal tract form the primary targets of chemotherapy-induced toxicities. Symptoms associated with damage to these regions have been clinically termed chemotherapy-induced cognitive impairment and mucositis. Whilst extensive literature outlines the complex et...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajic, Juliana E., Johnston, Ian N., Howarth, Gordon S., Hutchinson, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972222/
https://www.ncbi.nlm.nih.gov/pubmed/29872383
http://dx.doi.org/10.3389/fnbeh.2018.00104
_version_ 1783326396601335808
author Bajic, Juliana E.
Johnston, Ian N.
Howarth, Gordon S.
Hutchinson, Mark R.
author_facet Bajic, Juliana E.
Johnston, Ian N.
Howarth, Gordon S.
Hutchinson, Mark R.
author_sort Bajic, Juliana E.
collection PubMed
description The central nervous system and gastrointestinal tract form the primary targets of chemotherapy-induced toxicities. Symptoms associated with damage to these regions have been clinically termed chemotherapy-induced cognitive impairment and mucositis. Whilst extensive literature outlines the complex etiology of each pathology, to date neither chemotherapy-induced side-effect has considered the potential impact of one on the pathogenesis of the other disorder. This is surprising considering the close bidirectional relationship shared between each organ; the gut-brain axis. There are complex multiple pathways linking the gut to the brain and vice versa in both normal physiological function and disease. For instance, psychological and social factors influence motility and digestive function, symptom perception, and behaviors associated with illness and pathological outcomes. On the other hand, visceral pain affects central nociception pathways, mood and behavior. Recent interest highlights the influence of functional gut disorders, such as inflammatory bowel diseases and irritable bowel syndrome in the development of central comorbidities. Gut-brain axis dysfunction and microbiota dysbiosis have served as key portals in understanding the potential mechanisms associated with these functional gut disorders and their effects on cognition. In this review we will present the role gut-brain axis dysregulation plays in the chemotherapy setting, highlighting peripheral-to-central immune signaling mechanisms and their contribution to neuroimmunological changes associated with chemotherapy exposure. Here, we hypothesize that dysregulation of the gut-brain axis plays a major role in the intestinal, psychological and neurological complications following chemotherapy. We pay particular attention to evidence surrounding microbiota dysbiosis, the role of intestinal permeability, damage to nerves of the enteric and peripheral nervous systems and vagal and humoral mediated changes.
format Online
Article
Text
id pubmed-5972222
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59722222018-06-05 From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation Bajic, Juliana E. Johnston, Ian N. Howarth, Gordon S. Hutchinson, Mark R. Front Behav Neurosci Neuroscience The central nervous system and gastrointestinal tract form the primary targets of chemotherapy-induced toxicities. Symptoms associated with damage to these regions have been clinically termed chemotherapy-induced cognitive impairment and mucositis. Whilst extensive literature outlines the complex etiology of each pathology, to date neither chemotherapy-induced side-effect has considered the potential impact of one on the pathogenesis of the other disorder. This is surprising considering the close bidirectional relationship shared between each organ; the gut-brain axis. There are complex multiple pathways linking the gut to the brain and vice versa in both normal physiological function and disease. For instance, psychological and social factors influence motility and digestive function, symptom perception, and behaviors associated with illness and pathological outcomes. On the other hand, visceral pain affects central nociception pathways, mood and behavior. Recent interest highlights the influence of functional gut disorders, such as inflammatory bowel diseases and irritable bowel syndrome in the development of central comorbidities. Gut-brain axis dysfunction and microbiota dysbiosis have served as key portals in understanding the potential mechanisms associated with these functional gut disorders and their effects on cognition. In this review we will present the role gut-brain axis dysregulation plays in the chemotherapy setting, highlighting peripheral-to-central immune signaling mechanisms and their contribution to neuroimmunological changes associated with chemotherapy exposure. Here, we hypothesize that dysregulation of the gut-brain axis plays a major role in the intestinal, psychological and neurological complications following chemotherapy. We pay particular attention to evidence surrounding microbiota dysbiosis, the role of intestinal permeability, damage to nerves of the enteric and peripheral nervous systems and vagal and humoral mediated changes. Frontiers Media S.A. 2018-05-22 /pmc/articles/PMC5972222/ /pubmed/29872383 http://dx.doi.org/10.3389/fnbeh.2018.00104 Text en Copyright © 2018 Bajic, Johnston, Howarth and Hutchinson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Bajic, Juliana E.
Johnston, Ian N.
Howarth, Gordon S.
Hutchinson, Mark R.
From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
title From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
title_full From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
title_fullStr From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
title_full_unstemmed From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
title_short From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
title_sort from the bottom-up: chemotherapy and gut-brain axis dysregulation
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972222/
https://www.ncbi.nlm.nih.gov/pubmed/29872383
http://dx.doi.org/10.3389/fnbeh.2018.00104
work_keys_str_mv AT bajicjulianae fromthebottomupchemotherapyandgutbrainaxisdysregulation
AT johnstoniann fromthebottomupchemotherapyandgutbrainaxisdysregulation
AT howarthgordons fromthebottomupchemotherapyandgutbrainaxisdysregulation
AT hutchinsonmarkr fromthebottomupchemotherapyandgutbrainaxisdysregulation